- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
GlaxoSmithKline PLC
+ Add to WatchlistGSK:US
52.7681 USD 0.1719 0.32%As of 15:34:24 ET on 05/23/2013.
Snapshot for GlaxoSmithKline PLC (GSK)
| Open: | 52.5800 | Day's Range: | 52.3001 - 52.8600 | Volume: | 1,300,212 |
|---|---|---|---|---|---|
| Previous Close: | 52.9400 | 52wk Range: | 41.6800 - 53.4500 | 1-Yr Rtn: | +26.47% |
Key Statistics for GSK
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 14.9769 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (GBP) (ttm) | - |
| Est. EPS (GBP) (12/2013) | 2.3290 |
| Est. PEG Ratio | 2.4353 |
| Market Cap (M USD) | 129,912.45 |
| Shares Outstanding (M) | 2,463.73 |
| 30 Day Average Volume | 3,144,318 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 4.17% |
| Cash Dividend (USD) | 0.5502 |
| Last Dividend | 05/08/2013 |
| 5 Year Dividend Growth | 1.55% |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GSK
Company Profile & Key Executives for GSK
GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.
| Andrew WittyChief Executive Officer | Simon P DingemansChief Financial Officer |
| David RedfernChief Strategy Officer | Moncef SlaouiChairman:R&D & Vaccines |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GSK News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page